Otsuka Holdings Co., Ltd. revised consolidated earnings guidance for the Fiscal Year Ended December 31, 2023. For the year, company expects Revenue of JPY 2,018,000 million, Operating profit of JPY 139,000 million, Profit for the period of JPY 125,000 million, Profit attributable to owners of the Company of JPY 121,000 million and Basic earnings per share of JPY 222.97 previously forecasted as follows: Revenue of JPY 1,985,000 million, Operating profit of JPY 245,000 million, Profit for the period of JPY 192,000 million, Profit attributable to owners of the Company of JPY 188,000 million and Basic earnings per share of JPY 346.44.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,370 JPY | +1.56% | +2.97% | +20.44% |
Apr. 09 | H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy | MT |
Mar. 29 | Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.44% | 21.96B | |
+19.62% | 43.34B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B | |
-4.29% | 4.71B |
- Stock Market
- Equities
- 4578 Stock
- News Otsuka Holdings Co., Ltd.
- Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 31, 2023